Posts Tagged Ovarian

Recent Findings In Ovarian Cancer Described By Researchers From University Of The Sacred Heart

Research findings, ‘Review role of topotecan in gynaecological cancers: current indications and perspectives,’ are discussed in a new report. Ovarian cancer is the fourth cause of death from gynaecological cancer and cervical cancer is the first in women Critical Reviews In Oncology report. Source: General Cancer News Articles Provided by [...]

New Research On Ovarian Cancer From University Of Toronto

Scientists discuss in ‘Continuous docetaxel chemotherapy improves therapeutic efficacy in murine models of ovarian cancer’ new findings in ovarian cancer. Source: General Cancer News Articles Provided by Cancer Compass

Abbott Receives FDA Clearance for New Ovarian Cancer Test

The U.S. Food and Drug Administration (FDA) has cleared a new diagnostic test to monitor ovarian cancer, a disease that will strike an estimated one out of every 71 women in the United States in their lifetimes. Abbott’s new ARCHITECT HE4 (human epididymis protein 4) assay, the first automated [...]

Late-Stage Ovarian Cancer Shows Promise In Two-Drug Phase I Trial

The combination of decitabine and carboplatin appears to improve the outcome of women who have late-stage ovarian cancer. In an upcoming issue of the journal Cancer (online today), Indiana University researchers report four of 10 patients who participated in a phase I clinical trial had no disease progression after [...]

DiaTech Oncology MiCK Chemotherapy Induced Apoptosis Assay Shows Increased Response And Survival In Ovarian Cancer Patients

DiaTech Oncology announced that the American Society of Cancer Oncology (ASCO) has published the results of a comprehensive study to determine the effectiveness of the Microculture Kinetic (MiCK) assay for apoptosis in predicting increased response and survival rates for ovarian cancer patients. Source: General Cancer News Articles Provided by Cancer [...]

Hope for women in ovarian cancer fight: First advance in 20 years against ’silent killer’

Hope for women in ovarian cancer fight: First advance in 20 years against ’silent killer’ International trials show Avastin, already effective against breast and bowel cancers, gives women in the late stages of ovarian cancer an extra six months of life. Read more on Daily Mail

Research Findings From University Of Texas M.D. Anderson Cancer Center, M.D. Anderson Cancer Center Update Understanding Of Ovarian Cancer

Fresh data on ovarian cancer are presented in the report ‘Functional proteomic analysis of advanced serous ovarian cancer using reverse phase protein array: TGF-beta pathway signaling indicates response to primary chemotherapy. Source: General Cancer News Articles Provided by Cancer Compass

Research Data From Memorial Sloan-Kettering Cancer Center, Department of Surgery Update Understanding Of Ovarian Cancer

Fresh data on ovarian cancer are presented in the report ‘Genetic analysis of the early natural history of epithelial ovarian carcinoma.’ According to recent research from the United States, The high mortality rate associated with epithelial ovarian carcinoma (EOC) reflects diagnosis commonly at an advanced stage, but improved [...]

New Early Screening For Ovarian Cancer ‘Promising’

A new screening approach to detect early stage ovarian cancer in post-menopausal women has proven promising, researchers said of results to a study released Thursday. More than 70 percent of ovarian cancers are diagnosed when they have already grown to an advanced stage, so [...]

Findings In Ovarian Cancer Reported From M. Karkada And Co-Researchers

In light of lack of efficacy associated with current cancer vaccines, we aimed to develop a novel vaccine platform called DepoVax as a therapeutic vaccine for breast/ovarian cancer. This study was designed to examine the efficacy of this novel platform over conventional emulsion [...]